T. Drow

Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment

J. Galipeau, A. Balamurugan, P. Paul, 2022, Stem cells translational medicine.

Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models

P. Linsley, D. Liggitt, D. Rawlings, 2022, Science Translational Medicine.

Islet allografts expressing a PD‐L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

J. Galipeau, E. Nylen, P. Paul, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Chemically Inducible IL-2 Receptor Signaling Complex Allows for Effective In Vitro and In Vivo selection of Engineered CD4+ T cells.

A. Scharenberg, D. Rawlings, Annaiz M. Grimm, 2023, Molecular therapy : the journal of the American Society of Gene Therapy.